JP Morgan Chase
PALI icon

JP Morgan Chase’s Palisade Bio PALI Stock Holding History

JP Morgan Chase’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+64,715
New +$127K ﹤0.01% 5792
2024
Q4 		– Sell
-8,200
Closed -$29.1K – 7636
2024
Q3 		$29.1K Buy
+8,200
New +$31.6K ﹤0.01% 6151
2023
Q2 		– Sell
-42
Closed -$2K – 7228
2023
Q1 		$2K Sell
42
-32
-43% -$1.13K ﹤0.01% 6431
2022
Q4 		$6K Buy
+74
New +$4.29K ﹤0.01% 6133
2022
Q2 		– Sell
-1
Closed -$1K – 6761
2022
Q1 		$1K Buy
+1
New +$808 ﹤0.01% 6489
2014
Q2 		– Hold
0
– -$164K – 3600
2014
Q1 		– Hold
0
– – – 3437

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase's PALI Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Palisade Bio (PALI) in Q2 2026: 64,715 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #5792 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in PALI as recently as Q3 2024.

JP Morgan Chase first reported a position in PALI in Q1 2022 and has held it in 5 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • JP Morgan Chase held 64,715 shares of Palisade Bio worth $144K as of Q2 2026.
  • Palisade Bio was a new JP Morgan Chase position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5792 holding.
  • JP Morgan Chase first reported a position in Palisade Bio in Q1 2022 and has held it in 5 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.